Tariff-Based Compensation Framework
Infected Blood Inquiry · Second Interim Report · Issued 5 April 2023 · Addressed to: UK Government
Government responseUK Government: Accepted (May 2025)
DeliveryNo statement from UK Government found
Recommendation, verbatim from the inquiry
●Inquiry recommendation
I recommend that the Government should approve a scheme setting out a framework of tariff based compensation for eligible infected and affected persons, at rates which broadly take account of but are not limited by current practice in courts and tribunals across the UK and sums payable in other UK compensation schemes, and allowing an assessed basis for defined financial losses. The rates of compensation should be based on the advice of the independent clinical and legal panels and set by the scheme.
Infected Blood Inquiry, Second Interim Report · 5 Apr 2023 Source PDF →
Published evidence summary
AI-generated evidence summary
The Inquiry recommended that the Government approve a tariff-based compensation framework. The UK Government stated in May 2025 that the scheme would use a tariff-based framework with set criteria and rates to calculate payments, but it did not mention clinical and legal panel advice or assessed financial losses (Cabinet Office response, May 2025). The National Audit Office found in April 2026 that the scheme uses a tariff payment system awarding set amounts across five categories, including injury impact, social impact, autonomy, financial loss, and care awards (Gareth Davies, Apr 2026).
AI-generated summary of the record on this page, checked by a second model and automatic checks, 5 Oct 2026.
Government response
●UK Government · Accepted · 14 May 2025
In line with recommendation 8 of the Second Interim Report, the Scheme will use a tariff-based framework to calculate the amount of compensation payable to those eligible. In practice, this means that compensation will be calculated based on set criteria and rates. Using a tariff approach will minimise the amount of information that people applying to the Scheme are required to provide. It will also help to ensure that compensation can be awarded more quickly than would otherwise be possible if all applications for compensation had to be individually assessed.
Extract from: Full Government Response to the Infected Blood Inquiry's May 2024 Report
Delivery
No statement on delivery from UK Government has been found in the sources searched. This is separate from the response above.
What other bodies have found
●National Audit Office · 15 Apr 2026
The scheme uses a tariff payment system, where different levels of harm are awarded set amounts across five categories: injury impact, social impact, autonomy, financial loss, and care awards.
From: Government's compensation and financial recognition schemes, Gareth Davies, Comptroller and Auditor General
How this page is built
The recommendation and the government responses are verbatim from primary documents. Delivery statements and other bodies' findings are shown in their own words, each with its source. The summary is written by this site and labelled as such. The Index does not paraphrase sources or characterise intent; it records what has been published.